grant

PRECLINICAL DEVELOPMENT OF CANNABIS-DERIVED MEDICINES FOR DRUG-RESISTANT EPILEPSY [ 2019 - ]

Also known as: 5013236

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/GNT1161571]

Brief description Intractable childhood epilepsies have a large seizure burden and are associated with reduced lifespan and developmental delays. Recent successful human trials using cannabidiol (CBD) herald great promise for the future development of cannabinoids as novel anticonvulsants. We have discovered four cannabinoids that are more potent than CBD. In this project we aim to further develop these cannabinoids, and better understand the role of the natural cannabis system in childhood epilepsy.

Funding Amount $747,389.00

Funding Scheme Project Grants

Notes Standard Project Grant

Identifiers
Viewed: [[ro.stat.viewed]]